GS LHF 75 mg (Tafinlar 75 mg)

Generic Name: dabrafenib

Pill imprint GS LHF 75 mg has been identified as Tafinlar 75 mg.

Tafinlar is used in the treatment of melanoma, metastatic and belongs to the drug class multikinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Tafinlar 75 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for GS LHF 75 mg

Tafinlar 75 mg GS LHF 75 mg
Tafinlar
Generic Name:
dabrafenib
Imprint:
GS LHF
75 mg
Strength:
75 mg
Color:
Pink
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Multikinase inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
GlaxoSmithKline

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)